Evidence map›Paper›PMID 19678919›Full record

ArticleCritical care (London, England)2009

Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study.

Paul M Palevsky, Theresa Z O'Connor, Glenn M Chertow, Susan T Crowley, Jane Hongyuan Zhang, John A Kellum, US Department of Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network

2 registry-linked trialsAbstract read
In one paragraph

Article in Critical care (London, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00076219 phase3completednot on this map

CSP #530 - Intensive vs. Conventional Renal Support in Acute Renal Failure

TypeinterventionalSponsorUS Department of Veterans AffairsRan2003 to 2008Enrolled1,124ConditionsAcute Renal FailureArmsrenal replacement therapy
NCT05758077 narecruitingnot on this mapstarted 2023, after this paper: background citation

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients With Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy

TypeinterventionalSponsorSeaStar MedicalRan2023 to 2027Enrolled339ConditionsAcute Kidney InjuryArmsSelective Cytopheretic Device, Standard of Care
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Timing of kidney replacement therapy initiation for acute kidney injury.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Timing of renal replacement therapy initiation for acute kidney injury.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. Intensity of continuous renal replacement therapy for acute kidney injury.The Cochrane database of systematic reviews · 2016
    Pooled it
  5. Trial
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Review
  12. Renal Replacement Therapy in Severe Burns: A Multicenter Observational Study.Journal of burn care & research : official publication of the American Burn Association · 2018
    Observational
  13. Article
  14. Promoting Kidney Function Recovery in Patients with AKI Requiring RRT.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Review
  15. Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2015
    Article
  16. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2014
    Observational
  17. Dosing of renal replacement therapy in acute kidney injury.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2012
    Review
  18. Model to predict mortality in critically ill adults with acute kidney injury.Clinical journal of the American Society of Nephrology : CJASN · 2011
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul M PalevskyVA Pittsburgh Healthcare System, University Drive, Pittsburgh, PA 15240, USA. Palevsky@pitt.edu
Theresa Z O'Connor
Glenn M Chertow
Susan T Crowley
Jane Hongyuan Zhang
John A Kellum
US Department of Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network

Funding

NIDDK NIH HHS Y1-DK-3508-01
6 · The paper itself

Abstract

Determination of the optimal dose of renal replacement therapy in critically ill patients with acute kidney injury has been controversial. Questions have recently been raised regarding the design and execution of the US Department of Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network (ATN) Study, which demonstrated no improvement in 60-day all-cause mortality with more intensive management of renal replacement therapy. In the present article we present our rationale for these aspects of the design and conduct of the study, including our use of both intermittent and continuous modalities of renal support, our approach to initiation of study therapy and the volume management during study therapy. In addition, the article presents data on hypotension during therapy and recovery of kidney function in the perspective of other studies of renal support in acute kidney injury. Finally, we address the implications of the ATN Study results for clinical practice from the perspective of the study investigators.

Indexed as

Critical CareAcute Kidney InjuryHumansHypotensionMulticenter Studies as TopicOutcome Assessment, Health CareRandomized Controlled Trials as TopicRenal DialysisResearch DesignUnited StatesUnited States Department of Veterans Affairs

Identifiers

PMID19678919
PMCPMC2750132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.